Healthcare | April 07, 2026
World Health Day: Late diagnosis, rising lifestyle diseases put young India at risk
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group
Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
The patient, suffering from calcific severe aortic stenosis—a dangerous narrowing of the heart valve caused by calcium buildup—had run out of standard treatment options
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
Eylea 2mg (intravitreal aflibercept injection) is an anti-VEGF therapy that blocks a protein responsible for abnormal blood vessel growth and leakage in the retina
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
The program, which has been active for over a decade, will now expand its reach, focusing on equitable access to education, resources, and community-driven solutions for patients and care partners
Subscribe To Our Newsletter & Stay Updated
